649 - 660 of 7468 results

In this podcast episode, we will talk about how systolic hypertension affects outcomes, put into context a recent JACC systematic review paper on the topic and JNC 8. We will also discuss the Number Needed to Treat (NNT) and the Number Needed to Harm (NNH).

Recently, there has been a deluge of research and news surrounding e-cigarettes and vaping – particularly regarding adolescent usage. Join us as we discuss a recent study describing the prevalence of cannabis use in e-Cigarettes and some strategies for addressing this in your practice.


Join us as we discuss falls: a clinical issue that warrants regular assessment in adults over the age of 65.

In this week's podcast episode, we will identify the known health risks of OSA and outcomes of OSA treatment, discuss the new USPSTF screening recommendations on OSA and consider application of the new recommendations, known risks and outcomes of practice.

This episode reviews a study that looked at imaging that was performed over a one year period for women with a complaint of breast pain.

Cannabinoids include tetrahydrocannabinol (THC) and cannabidiol, which are found in marijuana, as well as synthetic compounds such as nabilone. The agents have been studied for the treatment of various chronic pain conditions. A meta-analysis was performed that analyzed any cannabinoid, for any chronic pain condition.

In this podcast episode, we will consider the rationale for using non-fasting labs to screen for ASCVD as well as review the controversies around their use and talk about the differential diagnosis of hypertriglyceridemia.


Plantar fasciitis is a common and often unsuccessfully treated chronic, painful condition. Multiple interventions have been suggested with varying degrees of effectiveness. Corticosteroid injections are sometimes used, but the evidence for efficacy has been limited with significant bias present in many of the trials. A Cochrane review in 2017 found a small degree of short-term benefit. Since then, a number of additional trials have been performed, and a newer systematic review finds no benefit.

Evidence of the efficacy of statins to reduce ASCVD morbidity and mortality in individuals > 75 years who have known clinical ASCVD (secondary prevention) is well established. Primary prevention in this population has not been as clear. Join us while we discuss a recent study in the BMJ which assessed the benefits of statins for primary prevention of ASCVD morbidity and mortality in individuals > 75 years with and without DM.

In this podcast episode, we will talk about the benefits of alpha antagonists on passing larger kidney stones as well as discuss the need for stone collection and analysis to prevent future stones. We will also learn how to effectively counsel patients about alpha antagonist use including risks and benefits.

This episode will review a randomized controlled trial of adding 10.5 grams of a soluble fiber, psyllium, to a Type 2 Diabetes diet and its influence on weight loss, BMI and other parameters of diabetes

In this podcast episode, we consider the premise of overdiagnosis and how it applies to women being screened for breast cancer and highlight ways to mitigate the risks of overdiagnosis of breast cancer.